These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Heparin binding by fibronectin module III-13 involves six discontinuous basic residues brought together to form a cationic cradle. Busby TF; Argraves WS; Brew SA; Pechik I; Gilliland GL; Ingham KC J Biol Chem; 1995 Aug; 270(31):18558-62. PubMed ID: 7629186 [TBL] [Abstract][Full Text] [Related]
3. The ShdA adhesin binds to the cationic cradle of the fibronectin 13FnIII repeat module: evidence for molecular mimicry of heparin binding. Kingsley RA; Keestra AM; de Zoete MR; Bäumler AJ Mol Microbiol; 2004 Apr; 52(2):345-55. PubMed ID: 15066025 [TBL] [Abstract][Full Text] [Related]
4. The Structure in Solution of Fibronectin Type III Domain 14 Reveals Its Synergistic Heparin Binding Site. Zhong X; Arnolds O; Krenczyk O; Gajewski J; Pütz S; Herrmann C; Stoll R Biochemistry; 2018 Oct; 57(42):6045-6049. PubMed ID: 30260627 [TBL] [Abstract][Full Text] [Related]
5. The heparin III-binding domain of fibronectin (III4-5 repeats) binds to fibronectin and inhibits fibronectin matrix assembly. Maqueda A; Moyano JV; Hernández Del Cerro M; Peters DM; Garcia-Pardo A Matrix Biol; 2007 Oct; 26(8):642-51. PubMed ID: 17611093 [TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of a conformational heparin-binding site involving two fibronectin type III modules of bovine tenascin-X. Lethias C; Elefteriou F; Parsiegla G; Exposito JY; Garrone R J Biol Chem; 2001 May; 276(19):16432-8. PubMed ID: 11278641 [TBL] [Abstract][Full Text] [Related]
7. Mapping the heparin-binding site on the 13-14F3 fragment of fibronectin. Sachchidanand ; Lequin O; Staunton D; Mulloy B; Forster MJ; Yoshida K; Campbell ID J Biol Chem; 2002 Dec; 277(52):50629-35. PubMed ID: 12377765 [TBL] [Abstract][Full Text] [Related]
8. Interaction of the NH2-terminal domain of fibronectin with heparin. Role of the omega-loops of the type I modules. Kishore R; Samuel M; Khan MY; Hand J; Frenz DA; Newman SA J Biol Chem; 1997 Jul; 272(27):17078-85. PubMed ID: 9202024 [TBL] [Abstract][Full Text] [Related]
9. Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin alpha5beta1: structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin. Kusano Y; Oguri K; Nagayasu Y; Munesue S; Ishihara M; Saiki I; Yonekura H; Yamamoto H; Okayama M Exp Cell Res; 2000 May; 256(2):434-44. PubMed ID: 10772816 [TBL] [Abstract][Full Text] [Related]
10. The high affinity heparin-binding domain and the V region of fibronectin mediate invasion of human oral squamous cell carcinoma cells in vitro. Kapila YL; Niu J; Johnson PW J Biol Chem; 1997 Jul; 272(30):18932-8. PubMed ID: 9228073 [TBL] [Abstract][Full Text] [Related]
11. Tenascin-C binds heparin by its fibronectin type III domain five. Weber P; Zimmermann DR; Winterhalter KH; Vaughan L J Biol Chem; 1995 Mar; 270(9):4619-23. PubMed ID: 7533163 [TBL] [Abstract][Full Text] [Related]
12. Localization of the major heparin-binding site in fibronectin. Barkalow FJ; Schwarzbauer JE J Biol Chem; 1991 Apr; 266(12):7812-8. PubMed ID: 2019604 [TBL] [Abstract][Full Text] [Related]
13. A synthetic peptide from the heparin-binding domain III (repeats III4-5) of fibronectin promotes stress-fibre and focal-adhesion formation in melanoma cells. Moyano JV; Maqueda A; Albar JP; Garcia-Pardo A Biochem J; 2003 Apr; 371(Pt 2):565-71. PubMed ID: 12519080 [TBL] [Abstract][Full Text] [Related]
14. Crystal structure of a heparin- and integrin-binding segment of human fibronectin. Sharma A; Askari JA; Humphries MJ; Jones EY; Stuart DI EMBO J; 1999 Mar; 18(6):1468-79. PubMed ID: 10075919 [TBL] [Abstract][Full Text] [Related]
15. Alternative splicing of the IIICS domain in fibronectin governs the role of the heparin II domain in fibrillogenesis and cell spreading. Santas AJ; Peterson JA; Halbleib JL; Craig SE; Humphries MJ; Peters DM J Biol Chem; 2002 Apr; 277(16):13650-8. PubMed ID: 11832485 [TBL] [Abstract][Full Text] [Related]
16. Interaction of heparin with a synthetic pentadecapeptide from the C-terminal heparin-binding domain of fibronectin. Hari SP; McAllister H; Chuang WL; Christ MD; Rabenstein DL Biochemistry; 2000 Apr; 39(13):3763-73. PubMed ID: 10736176 [TBL] [Abstract][Full Text] [Related]
17. Demonstration of structural differences between the two subunits of human-plasma fibronectin in the carboxy-terminal heparin-binding domain. Pande H; Calaycay J; Lee TD; Legesse K; Shively JE; Siri A; Borsi L; Zardi L Eur J Biochem; 1987 Jan; 162(2):403-11. PubMed ID: 3803394 [TBL] [Abstract][Full Text] [Related]
18. Identification of a novel heparin-binding site in the alternatively spliced IIICS region of fibronectin: roles of integrins and proteoglycans in cell adhesion to fibronectin splice variants. Mostafavi-Pour Z; Askari JA; Whittard JD; Humphries MJ Matrix Biol; 2001 Feb; 20(1):63-73. PubMed ID: 11246004 [TBL] [Abstract][Full Text] [Related]
19. Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism. Wijelath ES; Rahman S; Namekata M; Murray J; Nishimura T; Mostafavi-Pour Z; Patel Y; Suda Y; Humphries MJ; Sobel M Circ Res; 2006 Oct; 99(8):853-60. PubMed ID: 17008606 [TBL] [Abstract][Full Text] [Related]
20. Solution structure of a type 2 module from fibronectin: implications for the structure and function of the gelatin-binding domain. Pickford AR; Potts JR; Bright JR; Phan I; Campbell ID Structure; 1997 Mar; 5(3):359-70. PubMed ID: 9083105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]